Skip to main content
LFST logo

LifeStance Health Group, Inc. (LFST) Stock: Price, Forecast & Analyst Target

LifeStance Health Group, Inc. (LFST) — MoonshotScore 92/100 (Exceptional band), calculated Nov 18, 2026. Price $13.77 (-2.82%), as of the Nov 18, 2026 trading session; market cap $5.24B. Expected results Feb 24, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$13.77 −$0.40 (-2.82%) Market Cap $5.24B

LifeStance Health Group, Inc. · LFST · NASDAQ · Healthcare · Medical - Care Facilities

Research dated 2026-09-13: LifeStance delivers outpatient mental healthcare through a network of virtual and in-person centers across multiple states. The question is whether the business can scale profitable care delivery while managing reimbursement pressure and competition from larger healthcare systems.

Price as of Nov 18, 2026

Key Statistics

92 of 100

MoonshotScore v2 · LifeStance Health Group (LFST)

Exceptional
Business Quality Solid (75)
Financial Safety Sound (67)
Valuation Full (49)
Growth Durability Compounding (98)
Momentum Surging (98)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, but a full valuation; the market is already moving on it. Business Quality: Solid; Financial Safety: Sound; Valuation: Full; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 8 of the last 8 reports
  • Altman Z 5.26 · Piotroski F 8
  • ROE 4.8% · ROA 3.3% · current ratio 1.44 · earnings yield 1.3% · free-cash-flow yield 3.3%

Helping: business quality, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for LFST (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
92Exceptional
92Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$13.77
Change on the day-2.82%
52-week range$6.05–$15.66
Market capitalisation$5.24B—
Price / earnings (trailing)74.50
Shares traded on the day6.60M
Beta (volatility vs the S&P 500)1.3

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $4.90, high $14, latest $14. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $14 $4.90 high $14 Feb 25, 2026 · Earnings results · reported above the recorded estimate · close $7.241May 7, 2026 · Earnings results · reported above the recorded estimate · close $7.702Aug 6, 2026 · Earnings results · reported above the recorded estimate · close $113Nov 5, 2026 · Earnings results · reported above the recorded estimate · close $144 Oct 17, 2025 Nov 18, 2026 · $14 $5.04Oct 17, 2025$4.90Oct 31, 2025$6.40Nov 14, 2025$6.50Nov 28, 2025$6.91Dec 12, 2025$7.13Dec 26, 2025$7.40Jan 9, 2026$7.34Jan 23, 2026$6.83Feb 6, 2026$7.15Feb 20, 2026$6.93Mar 6, 2026$6.40Mar 20, 2026$6.31Apr 2, 2026$6.89Apr 17, 2026$7.53May 1, 2026$7.65May 15, 2026$7.71May 29, 2026$8.50Jun 12, 2026$10Jun 26, 2026$11Jul 10, 2026$11Jul 24, 2026$11Aug 7, 2026$12Aug 21, 2026$13Sep 4, 2026$13Sep 18, 2026$12Oct 2, 2026$12Oct 16, 2026$13Oct 30, 2026$14Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for LifeStance Health Group (LFST): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Moderate
Valuation Neutral
Growth Durability Strong
Momentum Strong

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Debt/Equity Neutral
ROE Weak
Gross Margin Neutral

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is LifeStance Health Group (LFST), and what does it report?

Short answer · as of

LifeStance offers psychiatric evaluations, psychological testing, therapy (individual, family, group), and treatment across a spectrum of mental health conditions.

Patients access care virtually or at physical locations in states across the country. The business serves children, adolescents, adults, and the elderly. Revenue comes from insurance reimbursements, patient copays, and employer contracts for employee mental health benefits. The income statement shows improving margins as the company scales and achieves better payor mix and operational leverage.

The operating model is capital-light compared to traditional brick-and-mortar mental health centers. Virtual delivery reduces facility costs while maintaining quality of care.

2 · Latest results

What do the latest results show for LifeStance Health Group (LFST)?

The most recent quarter showed improved profitability and earnings that beat analyst expectations, while revenue also came in ahead of estimates. This suggests the company is moving toward sustainable unit economics and scale. The gross margin expanded, driven by better payor mix and operational efficiency as patient volumes grow.

Management commentary emphasizes revenue growth and path to profitability. The company guides to accelerating earnings in subsequent periods, suggesting confidence in both volume growth and margin expansion.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$455.86M Nov 5, 2026
Latest report · revenue estimate
$431.59M Nov 5, 2026
Latest report · revenue vs estimate
Above estimate Nov 5, 2026
Latest report · EPS vs estimate
Above estimate Nov 5, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 5, 2026$455.86M$431.59M$0.0600$0.0369
Aug 6, 2026$435.35M$414.58M$0.0600$0.0328
May 7, 2026$403.50M$387.46M$0.0400$0.0100
Feb 25, 2026$382.20M$378.42M$0.0300−$0.0009
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$364M$1M$0.0028 (diluted)
Q4 FY2025$382M$12M—
Q1 FY2026$403M$14M$0.04 (diluted)
Q2 FY2026$435M$24M$0.06 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for LifeStance Health Group (LFST)?

Short answer · as of

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

The company has a strong balance sheet with modest debt and a quick ratio above unity, indicating no near-term liquidity pressure. Operating cash generation is positive and robust, exceeding capital needs. The Altman score shows healthy distance from distress. Return on assets and return on equity are improving, reflecting the path to sustained profitability.

The main financial risk is reimbursement pressure from payors, which could squeeze margins if the company cannot offset with volume or operational improvement. Competitive intensity from larger healthcare systems entering mental health could also pressure pricing power.

4 · What to check next?

What should you watch next at LifeStance Health Group (LFST)?

Short answer · as of

The next earnings report is expected on Feb 24, 2027.

The next earnings will show whether revenue growth continues and whether margins stabilize at the new higher level. Watch for any commentary on payor mix shifts, changes in reimbursement rates, or competitive pressures. Also monitor patient satisfaction metrics and retention, as these drive long-term sustainability.

The company's ability to expand into new states and verticals while maintaining profitability will determine whether the growth story continues. Any significant setback in payor negotiations or patient acquisition would pressure the valuation.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does LifeStance Health Group compare with its peers?

Short answer

LifeStance Health Group's score ranks 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

LifeStance differs from traditional mental health providers in that it emphasizes virtual delivery and broad geographic reach, reducing geographic arbitrage and enabling rapid expansion. It differs from pure-play behavioral health startups in that it maintains physical centers as well, giving patients choice and broadening addressable market.

The competitive field includes large healthcare systems, telehealth platforms, and specialized behavioral health pure-plays. LifeStance's positioning as a hybrid (virtual + physical) with institutional backing differentiates it.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Addus HomeCare Corporation (ADUS) Same industry, near in market value$120.85 Nov 18, 2026$2.25B93 5-pillar Nov 18, 2026
LifeStance Health Group (LFST) — this page$13.77$5.24B92
Universal Health Services, Inc. (UHS) Same industry, near in market value$186.07 Nov 18, 2026$10.7B91 5-pillar Nov 18, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.71 Nov 18, 2026$4.75B85 5-pillar Nov 18, 2026
Chemed Corporation (CHE) Same industry, near in market value$546.72 Nov 18, 2026$7.09B85 5-pillar Nov 18, 2026
Pediatrix Medical Group, Inc. (MD) Same industry, near in market value$30.84 Nov 18, 2026$2.41B82 5-pillar Nov 18, 2026
Encompass Health Corporation (EHC) Same industry, near in market value$134.94 Nov 18, 2026$13.2B81 5-pillar Nov 18, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$20.95 Nov 18, 2026$10.9B80 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$201.60 Nov 18, 2026$3.16B76 5-pillar Nov 18, 2026
DaVita Inc. (DVA) Same industry, near in market value$161.75 Nov 18, 2026$10.2B76 5-pillar Nov 18, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Same industry, near in market value$10.85 Nov 18, 2026$2.37B75 5-pillar Nov 18, 2026
The Ensign Group, Inc. (ENSG) Same industry, near in market value$182.98 Nov 18, 2026$10.7B74 5-pillar Nov 18, 2026
MiniMed Group, Inc. Common Stock (MMED) Same industry, near in market value$16.99 Nov 18, 2026$4.78B38 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$9.00 – $19.00
Consensus target
$14.14
Median target
$15.00

Consensus record · Captured .

Measured against a quoted price of $13.77 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 12, 2026

Transactions
36
Identified insiders
13
Purchases
0
Sales
17
Other transactions
19

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held LFST in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported LFST in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about LifeStance Health Group (LFST)?

Read these with our analysis →

LifeStance Health Group Healthcare Stock: Key Questions Answered

The last 2 questions are answered from this page's own dated data, not from the research.

What is the business model for mental health delivery?

LifeStance contracts with insurance companies and employers for mental health services. Patients pay copays; payers reimburse the company. The company manages clinician networks (employed or contracted) and coordinates care delivery. Revenue grows as patient volume and contract value expand; margins expand as operational scale improves. The model requires scale to be profitable, as fixed costs for infrastructure and administration are high relative to marginal cost per patient visit.

What are the main risks to the margin expansion story?

Payor reimbursement rates could fall, squeezing gross margins. Clinician wages could rise faster than reimbursement, compressing operating margins. Competitive intensity from larger health systems entering the market could pressure pricing and patient acquisition costs. Regulatory changes in licensing, telehealth coverage, or insurance policy could shift the addressable market or cost structure unexpectedly.

Is management buying or selling shares?

Recent insider activity shows significant sales by company insiders, concentrated around certain price levels and dates. The sellers are CFOs, founders, and executives, which could signal either profit-taking or concern about near-term prospects. The scale of selling relative to institutional ownership is material enough to warrant monitoring but not so extreme as to suggest a crisis of confidence.

How does LifeStance compare to larger healthcare systems entering mental health?

Larger systems (Humana, CVS, United Health) have vast scale, integrated insurance and care, and established payor relationships. LifeStance has specialized focus, lower cost structure, and agility. Neither has inherent superiority; market share will likely be split by geography and payor preference. LifeStance's advantage is that mental health is a small segment of large systems' business, so they may under-invest while LifeStance keeps innovating.

What is the LFST stock price today?

The last price recorded for LifeStance Health Group, Inc. (LFST), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the LFST price target?

The analyst consensus price target for LifeStance Health Group, Inc. (LFST), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 43 figures on this page — 1 from SEC filings and earnings calls, 35 from Financial Modeling Prep (FMP), 4 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Sector / industry (provider taxonomy); Annual revenue and net result (USD millions)
  • 1. What is LifeStance Health Group (LFST), and what does it report?: Business description; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)
  • 2. What do the latest results show for LifeStance Health Group (LFST)?: Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Annual revenue and net result (USD millions)
  • 3. What are the financial strengths and risks for LifeStance Health Group (LFST)?: Cash, investments and debt; Operating cash flow by quarter (USD millions); Trailing twelve-month ratio set
  • 4. What should you watch next at LifeStance Health Group (LFST)?: Next earnings report; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands)
  • 5. How does LifeStance Health Group compare with its peers?: Business description; Annual revenue and net result (USD millions); Analyst actions, most recent per firm
  • FAQ: What is the business model for mental health delivery?: Business description; Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions)
  • FAQ: What are the main risks to the margin expansion story?: Trailing twelve-month ratio set; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands)
  • FAQ: Is management buying or selling shares?: Insider transactions, last 180 days; Institutional ownership (13F); Named officers
  • FAQ: How does LifeStance compare to larger healthcare systems entering mental health?: Business description; Analyst actions, most recent per firm; Annual revenue and net result (USD millions)
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.